Literature DB >> 15706436

Roles of thymosins in cancers and other organ systems.

Changyi Chen1, Min Li, Hui Yang, Hong Chai, William Fisher, Qizhi Yao.   

Abstract

Thymosins are small peptides, originally identified from the thymus, but now known to be more widely distributed in many tissues and cells. Thymosins are divided into three main groups, alpha-, beta-, : and gamma-thymosins, based on their isoelectric points. alpha-thymosins (ProTalpha, Talphal) have nuclear localization and are involved in transcription and/or DNA replications; whereas beta-thymosins (Tbeta4, Tbeta10, Tbetal5) have cytoplasmic localization and show high affinity to G-actin for cell mobility. Furthermore, it is well known that both alpha- and beta-thymosins play important roles in modulating immune response, vascular biology, and cancer pathogenesis. More importantly, thymosins may have significant clinical applications. They may serve as molecular markers for the diagnosis and prognosis of certain diseases. In addition, they could be molecular targets of certain diseases or be used as therapeutic agents to treat certain diseases. However, the molecular mechanisms of action of thymosins are largely unknown. This review not only presents recent advances of basic science research of thymosins and their clinical applications but provides thoughtful views for future directions of investigation on thymosins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15706436     DOI: 10.1007/s00268-004-7817-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  133 in total

1.  Cellular levels of thymosin immunoreactive peptides are linked to proliferative events: evidence for a nuclear site of action.

Authors:  C N Conteas; M G Mutchnick; K C Palmer; F E Weller; G D Luk; P H Naylor; M R Erdos; A L Goldstein; C Panneerselvam; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

2.  Prothymosin alpha: a biologically active protein with random coil conformation.

Authors:  K Gast; H Damaschun; K Eckert; K Schulze-Forster; H R Maurer; M Müller-Frohne; D Zirwer; J Czarnecki; G Damaschun
Journal:  Biochemistry       Date:  1995-10-10       Impact factor: 3.162

3.  Overexpression of prothymosin alpha accelerates proliferation and retards differentiation in HL-60 cells.

Authors:  P Rodríguez; J E Viñuela; L Alvarez-Fernández; M Buceta; A Vidal; F Domínguez; J Gómez-Márquez
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

4.  Immunoregulatory effects of fraction 5 thymus peptides. I. Thymosin alpha 1 enhances while thymosin beta 4 suppresses the human autologous and allogeneic mixed lymphocyte reaction.

Authors:  C N Baxevanis; G J Reclos; S Perez; D Kokkinopoulos; M Papamichail
Journal:  Immunopharmacology       Date:  1987-04

5.  Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes.

Authors:  M M Zatz; J Oliver; C Samuels; A B Skotnicki; M B Sztein; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

6.  Prothymosin alpha is an evolutionary conserved protein covalently linked to a small RNA.

Authors:  T Makarova; N Grebenshikov; C Egorov; A Vartapetian; A Bogdanov
Journal:  FEBS Lett       Date:  1989-11-06       Impact factor: 4.124

7.  Thymosin alpha 1 protects liver and aorta from oxidative damage in atherosclerotic rabbits.

Authors:  C Gökkusu; E Ademoğlu; U M Türkoğlu; H Oz; F Oz
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

8.  Prothymosin alpha modulates the interaction of histone H1 with chromatin.

Authors:  Z Karetsou; R Sandaltzopoulos; M Frangou-Lazaridis; C Y Lai; O Tsolas; P B Becker; T Papamarcaki
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

9.  Prothymosin alpha receptors on lymphocytes.

Authors:  O J Cordero; C Sarandeses; M Nogueira
Journal:  J Interferon Cytokine Res       Date:  1995-08       Impact factor: 2.607

10.  Distribution of prothymosin alpha in rat tissues.

Authors:  A A Haritos; O Tsolas; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

View more
  23 in total

1.  Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.

Authors:  Jing You; Lin Zhuang; Hong-Ying Cheng; Shou-Ming Yan; Lan Yu; Jun-Hua Huang; Bao-Zhang Tang; Meng-Ling Huang; Yong-Liang Ma; Virasakdi Chongsuvivatwong; Hutcha Sriplung; Alan Geater; Yan-Wei Qiao; Rong-Xue Wu
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

2.  AcSDKP: a new potential marker of malignancy of the thyroid gland.

Authors:  Michal Kusinski; Joanna Wdzieczak-Bakala; Jian-Miao Liu; Jerome Bignon; Krzysztof Kuzdak
Journal:  Langenbecks Arch Surg       Date:  2006-01-18       Impact factor: 3.445

Review 3.  Adamantinomatous craniopharyngioma: advances in proteomic research.

Authors:  Claudia Desiderio; Diana Valeria Rossetti; Massimo Castagnola; Luca Massimi; Gianpiero Tamburrini
Journal:  Childs Nerv Syst       Date:  2020-07-02       Impact factor: 1.475

4.  Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.

Authors:  Jo Caers; Dirk Hose; Ine Kuipers; Tomas Jan Bos; Els Van Valckenborgh; Eline Menu; Elke De Bruyne; Hartmut Goldschmidt; Ben Van Camp; Bernard Klein; Karin Vanderkerken
Journal:  Haematologica       Date:  2009-10-14       Impact factor: 9.941

Review 5.  Thymosin beta4 and Ac-SDKP: tools to mend a broken heart.

Authors:  Alex Rossdeutsch; Nicola Smart; Paul R Riley
Journal:  J Mol Med (Berl)       Date:  2007-08-15       Impact factor: 4.599

6.  Thymosin beta 4 expression in normal skin, colon mucosa and in tumor infiltrating mast cells.

Authors:  S Nemolato; T Cabras; M U Fanari; F Cau; M Fraschini; B Manconi; I Messana; M Castagnola; G Faa
Journal:  Eur J Histochem       Date:  2010-02-16       Impact factor: 3.188

7.  Expression pattern of thymosin beta 4 in the adult human liver.

Authors:  S Nemolato; P Van Eyken; T Cabras; F Cau; M U Fanari; A Locci; D Fanni; C Gerosa; I Messana; M Castagnola; G Faa
Journal:  Eur J Histochem       Date:  2011-08-27       Impact factor: 3.188

8.  Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.

Authors:  Weina Li; Liqiang Song; Shouzhen Wu; Xiaochang Xue; Lu Zhang; Liqing He; Wei Han; Qing Wang; Rui Ling; Wei Zhang; Zhen Yan; Yingqi Zhang
Journal:  Int J Biol Sci       Date:  2011-05-19       Impact factor: 6.580

9.  The Escherichia coli-derived thymosin β4 concatemer promotes cell proliferation and healing wound in mice.

Authors:  Xiaolei Wang; Guihua Yang; Shanshuang Li; Meifeng Gao; Pangfeng Zhao; Lingxia Zhao
Journal:  Biomed Res Int       Date:  2013-05-19       Impact factor: 3.411

10.  Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer.

Authors:  S Darb-Esfahani; R Kronenwett; G von Minckwitz; C Denkert; M Gehrmann; A Rody; J Budczies; J C Brase; M K Mehta; H Bojar; B Ataseven; T Karn; E Weiss; D M Zahm; F Khandan; M Dietel; S Loibl
Journal:  Br J Cancer       Date:  2012-10-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.